Medtecs International Corporation Ltd DRC (9103) - Net Assets
Based on the latest financial reports, Medtecs International Corporation Ltd DRC (9103) has net assets worth NT$102.11 Million TWD (≈ $3.22 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$146.11 Million ≈ $4.60 Million USD) and total liabilities (NT$44.00 Million ≈ $1.39 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 9103 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$102.11 Million |
| % of Total Assets | 69.89% |
| Annual Growth Rate | 4.48% |
| 5-Year Change | -45.66% |
| 10-Year Change | 65.07% |
| Growth Volatility | 49.84 |
Medtecs International Corporation Ltd DRC - Net Assets Trend (2009–2025)
This chart illustrates how Medtecs International Corporation Ltd DRC's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Medtecs International Corporation Ltd DR stock valuation.
Annual Net Assets for Medtecs International Corporation Ltd DRC (2009–2025)
The table below shows the annual net assets of Medtecs International Corporation Ltd DRC from 2009 to 2025. Also explore Medtecs International Corporation Ltd DR annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$102.11 Million ≈ $3.22 Million |
-4.62% |
| 2024-12-31 | NT$107.05 Million ≈ $3.37 Million |
-17.85% |
| 2023-12-31 | NT$130.31 Million ≈ $4.11 Million |
-14.45% |
| 2022-12-31 | NT$152.31 Million ≈ $4.80 Million |
-18.94% |
| 2021-12-31 | NT$187.91 Million ≈ $5.92 Million |
-3.38% |
| 2020-12-31 | NT$194.49 Million ≈ $6.13 Million |
+201.11% |
| 2019-12-31 | NT$64.59 Million ≈ $2.03 Million |
+1.96% |
| 2018-12-31 | NT$63.35 Million ≈ $2.00 Million |
+0.68% |
| 2017-12-31 | NT$62.92 Million ≈ $1.98 Million |
+1.72% |
| 2016-12-31 | NT$61.86 Million ≈ $1.95 Million |
+2.31% |
| 2015-12-31 | NT$60.46 Million ≈ $1.90 Million |
+7.50% |
| 2014-12-31 | NT$56.24 Million ≈ $1.77 Million |
-0.51% |
| 2013-12-31 | NT$56.53 Million ≈ $1.78 Million |
-0.05% |
| 2012-12-31 | NT$56.56 Million ≈ $1.78 Million |
+3.58% |
| 2011-12-31 | NT$54.60 Million ≈ $1.72 Million |
+2.16% |
| 2010-12-31 | NT$53.45 Million ≈ $1.68 Million |
+5.52% |
| 2009-12-31 | NT$50.65 Million ≈ $1.60 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Medtecs International Corporation Ltd DRC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | NT$27.50 Million | 27.07% |
| Other Comprehensive Income | NT$-1.09 Million | -1.08% |
| Other Components | NT$75.21 Million | 74.01% |
| Total Equity | NT$101.62 Million | 100.00% |
Medtecs International Corporation Ltd DRC Competitors by Market Cap
The table below lists competitors of Medtecs International Corporation Ltd DRC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TC Bancshares Inc
NASDAQ:TCBC
|
$85.22 Million |
|
Kumkang Kind
KO:014280
|
$84.57 Million |
|
ASolid Technology Co Ltd
TWO:6485
|
$84.68 Million |
|
Enterprise Group Inc
TO:E
|
$86.97 Million |
|
Maywood Acquisition Corp. Unit
NASDAQ:MAYAU
|
$85.11 Million |
|
New Delhi Television Limited
NSE:NDTV
|
$86.68 Million |
|
Max India Limited
NSE:MAXIND
|
$85.39 Million |
|
Rich Honour International Designs Co Ltd
TW:6754
|
$86.92 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medtecs International Corporation Ltd DRC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 106,571,000 to 101,623,206, a change of -4,947,794 (-4.6%).
- Net loss of 4,801,937 reduced equity.
- Other comprehensive income decreased equity by 228,326.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-4.80 Million | -4.73% |
| Other Comprehensive Income | NT$-228.33K | -0.22% |
| Other Changes | NT$82.47K | +0.08% |
| Total Change | NT$- | -4.64% |
Book Value vs Market Value Analysis
This analysis compares Medtecs International Corporation Ltd DRC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 26.60x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 44.83x to 26.60x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | NT$0.11 | NT$4.96 | x |
| 2010-12-31 | NT$0.12 | NT$4.96 | x |
| 2011-12-31 | NT$0.12 | NT$4.96 | x |
| 2012-12-31 | NT$0.12 | NT$4.96 | x |
| 2013-12-31 | NT$0.12 | NT$4.96 | x |
| 2014-12-31 | NT$0.12 | NT$4.96 | x |
| 2015-12-31 | NT$0.12 | NT$4.96 | x |
| 2016-12-31 | NT$0.11 | NT$4.96 | x |
| 2017-12-31 | NT$0.11 | NT$4.96 | x |
| 2018-12-31 | NT$0.11 | NT$4.96 | x |
| 2019-12-31 | NT$0.12 | NT$4.96 | x |
| 2020-12-31 | NT$0.35 | NT$4.96 | x |
| 2021-12-31 | NT$0.34 | NT$4.96 | x |
| 2022-12-31 | NT$0.27 | NT$4.96 | x |
| 2023-12-31 | NT$0.24 | NT$4.96 | x |
| 2024-12-31 | NT$0.20 | NT$4.96 | x |
| 2025-12-31 | NT$0.19 | NT$4.96 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Medtecs International Corporation Ltd DRC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -4.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -6.13%
- • Asset Turnover: 0.54x
- • Equity Multiplier: 1.44x
- Recent ROE (-4.73%) is below the historical average (2.23%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 3.71% | 3.11% | 0.56x | 2.12x | NT$-3.03 Million |
| 2010 | 2.76% | 3.10% | 0.40x | 2.23x | NT$-3.68 Million |
| 2011 | 3.31% | 3.17% | 0.50x | 2.11x | NT$-3.48 Million |
| 2012 | 2.43% | 2.50% | 0.46x | 2.10x | NT$-4.08 Million |
| 2013 | 1.14% | 1.10% | 0.50x | 2.07x | NT$-4.78 Million |
| 2014 | 0.69% | 0.74% | 0.49x | 1.90x | NT$-5.14 Million |
| 2015 | 0.89% | 0.86% | 0.56x | 1.84x | NT$-5.41 Million |
| 2016 | 1.68% | 1.77% | 0.55x | 1.74x | NT$-5.06 Million |
| 2017 | 1.43% | 1.43% | 0.56x | 1.77x | NT$-5.31 Million |
| 2018 | 1.47% | 1.34% | 0.61x | 1.81x | NT$-5.32 Million |
| 2019 | 1.83% | 1.68% | 0.59x | 1.83x | NT$-5.20 Million |
| 2020 | 68.08% | 32.90% | 1.63x | 1.27x | NT$112.36 Million |
| 2021 | 9.36% | 12.03% | 0.67x | 1.16x | NT$-1.18 Million |
| 2022 | -19.09% | -50.84% | 0.31x | 1.22x | NT$-43.57 Million |
| 2023 | -16.30% | -40.02% | 0.32x | 1.29x | NT$-33.99 Million |
| 2024 | -20.67% | -40.47% | 0.39x | 1.30x | NT$-32.68 Million |
| 2025 | -4.73% | -6.13% | 0.54x | 1.44x | NT$-14.96 Million |
Industry Comparison
This section compares Medtecs International Corporation Ltd DRC's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,927,964,400
- Average return on equity (ROE) among peers: 12.96%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medtecs International Corporation Ltd DRC (9103) | NT$102.11 Million | 3.71% | 0.43x | $85.15 Million |
| St.Shine Optical Co Ltd (1565) | $2.47 Billion | 35.35% | 0.46x | $153.28 Million |
| Maxigen Biotech Inc (1783) | $1.38 Billion | 13.83% | 0.15x | $102.58 Million |
| SciVision Biotech Inc (1786) | $111.73 Million | -6.14% | 1.00x | $100.20 Million |
| Bioteque (4107) | $3.44 Billion | 15.35% | 0.35x | $243.43 Million |
| Chi Sheng Chemical (4111) | $1.27 Billion | 8.68% | 0.37x | $54.10 Million |
| BenQ Medical Technology (4116) | $1.09 Billion | 6.10% | 0.54x | $55.53 Million |
| Pacific Hospital Supply Co Ltd (4126) | $1.64 Billion | 19.09% | 0.21x | $177.95 Million |
| Bionime Corp (4737) | $1.07 Billion | 8.40% | 3.23x | $146.83 Million |
| Vizionfocus Inc. (4771) | $4.42 Billion | 18.28% | 0.60x | $393.98 Million |
| Formosa Optical Technology Co Ltd (5312) | $2.38 Billion | 10.63% | 0.86x | $170.87 Million |
About Medtecs International Corporation Ltd DRC
Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients'… Read more